Andrew Blight, Chief Scientifc Officer at ACORDA THERAPEUTICS INC (ACOR), sold 13,085 shares at $30.85 ($410K) on 2015-09-21, disclosed to the SEC on 2015-09-23.
Scheduled sale ($410k) by Chief Scientifc Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.85 | 6,894 | $213K | 51.9% |
| 2 | $31.81 | 6,191 | $197K | 48.1% |
| Total | $31.30 avg | 13,085 | $410K | 100% |
| Filing → |
| ACOR | SELL | 2015-11-23 | $19K | — | Filing → |
| ACOR | SELL | 2015-10-21 | $1.0M | — | Filing → |
| ACOR | SELL | 2014-10-22 | $1.7M | — | Filing → |